SEC Form 4 · accession 0001209191-17-041678
Clearside Biomedical, Inc. · CLSD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay Thorp
Director · 10% Owner
Period of report
Jun 22, 2017
Accepted (ET)
Jun 23, 2017 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.81 | Jun 22, 2017 | A | 8,618 | A | — | Jun 21, 2027 | Common Stock | 8,618 | 8,618 | D |
Explanation of responses
- F1The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2018.